{"id":831,"date":"2016-06-14T15:57:18","date_gmt":"2016-06-14T13:57:18","guid":{"rendered":"https:\/\/alzheimer.noemi.lu\/?p=831"},"modified":"2024-06-28T14:16:08","modified_gmt":"2024-06-28T13:16:08","slug":"epad-partners-voice-concern-for-future-of-dementia-research-if-britain-leaves-eu","status":"publish","type":"post","link":"https:\/\/ep-ad.org\/index.php\/2016\/06\/14\/epad-partners-voice-concern-for-future-of-dementia-research-if-britain-leaves-eu\/","title":{"rendered":"EPAD and EMIF partners voice concern for future of dementia research if Britain leaves EU"},"content":{"rendered":"<p>Partners from two of the most important research programmes in the dementia field &#8211; the European Prevention of Alzheimer\u2019s Dementia (EPAD) initiative and the European Medical Information Framework (EMIF) &#8211; have published an article in the journal Lancet Psychiatry, titled \u201cBetter together for better dementia research and care\u201d in the run up to the UK\u2019s historic \u201cEU Referendum\u201d of 23 June. Voters will decide whether or not the UK should continue to be a Member State of the European Union (EU).<\/p>\n<p>They argue that the EU has made dementia research a priority and has made substantial funds available for research that is driving faster, more effective clinical trials, which they say is the best hope of finding a disease-modifying therapy.<\/p>\n<p>Both EMIF and EPAD are funded through the Innovative Medicines Initiative (IMI), a funding stream including both EU funding and matching funds from pharmaceutical industries. Both projects are led by UK partners and bring over EUR 17 million in direct funding to the UK.<\/p>\n<p>Through the four IMI programmes that are focused on dementia, 24 UK institutions receive funding. In addition to IMI, dementia funding across Europe receives strong support from schemes such as the Centres of Excellence Network and the Joint Programme \u2013 Neurodegenerative Disease Research (JPND). These collaborative programmes bring UK researchers together with some of the best scientists from across Europe, bring substantial funding to the UK and leverage funds from industry.<\/p>\n<p>This research is also dependent on the free movement of scientists across Europe point out the authors. Collaboration between UK and EU scientists \u201cbrings knowledge, skills, and a vibrancy and energy to our work that would be missing were we not to be part of the EU\u201d.<\/p>\n<p>\u201cAs well as research, our membership in the EU enhances the patient and carer voice and contributes to best practice. Through our collaboration in Europe we have learnt from clinical service developments, refined tests and diagnostics, and through working closely with pan-European patient organisations, such as Alzheimer Europe, we are able to speak with a clearer, louder, and more consistent voice\u201d the article concludes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Partners from two of the most important research programmes in the dementia field &#8211; the European Prevention of Alzheimer\u2019s Dementia (EPAD) initiative and the European Medical Information Framework (EMIF) &#8211; have published an article in the journal Lancet Psychiatry, titled \u201cBetter together for better dementia research and care\u201d in the run up to the UK\u2019s [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":833,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-831","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/comments?post=831"}],"version-history":[{"count":1,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/831\/revisions"}],"predecessor-version":[{"id":10424,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/831\/revisions\/10424"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/media\/833"}],"wp:attachment":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/media?parent=831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/categories?post=831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/tags?post=831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}